319925-34-3 Usage
Furanone ring
The compound contains a furanone ring, which is a five-membered heterocyclic ring with an oxygen atom and a double bond between two of the carbon atoms.
Heptenyl chain
The compound has a heptenyl chain, which is a carbon chain with seven carbon atoms and one double bond between two of the carbon atoms.
Chiral molecule
The compound is a chiral molecule, meaning it has a stereocenter and can exist in different forms that are mirror images of each other.
Stereocenter
The compound has a stereocenter at the 4th and 5th positions, which gives it its chirality.
Diphenylsilyloxy group
The compound contains a diphenylsilyloxy group, which is a group consisting of two phenyl rings attached to a silicon atom, and a silicon-oxygen bond.
Potential applications
The compound may have potential applications in the pharmaceutical, agricultural, or material science industries due to its unique structure and properties.
Further research needed
Further research and analysis are needed to fully understand the compound's potential uses and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 319925-34-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,9,9,2 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 319925-34:
(8*3)+(7*1)+(6*9)+(5*9)+(4*2)+(3*5)+(2*3)+(1*4)=163
163 % 10 = 3
So 319925-34-3 is a valid CAS Registry Number.
319925-34-3Relevant academic research and scientific papers
A novel stereoselective access to substituted L-2-deoxypentono-1,4-lactones and L-2-deoxypentoses
Johnson, Dean V.,Fischer, Roland,Griengl, Herfried
, p. 9289 - 9295 (2007/10/03)
A stereoselective method to L-2-deoxypentose or L-2-deoxy-pentono-1,4-lactone units was developed employing the (S)-Hydroxynitrile lyase from Hevea brasiliensis. Additionally a diastereoselective reduction using either (D)- or (L)-tartaric acid in conjuction with sodium borohydride had been applied to control the ultimate stereochemistry of the bioactive compounds. (C) 2000 Elsevier Science Ltd.
